ABVC vs DOCU · rev $509.6K vs P/E 15, rev $2.98B
ABVC Biopharma Inc (ABVC) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
DocuSign Inc (DOCU) is a software - application company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
ABVC currently screens at market cap $35.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the ABVC and DOCU stock pages for the full models.
Not investment advice.